Detalhe da pesquisa
1.
Proof of concept studies for siRNA delivery by nonionic surfactant vesicles: in vitro and in vivo evaluation of protein knockdown.
J Liposome Res
; 29(3): 229-238, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30296860
2.
Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polyethylenimine polyplex.
Nanomedicine
; 7(5): 615-23, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21333755
3.
Regression of Melanoma Following Intravenous Injection of Plumbagin Entrapped in Transferrin-Conjugated, Lipid-Polymer Hybrid Nanoparticles.
Int J Nanomedicine
; 16: 2615-2631, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33854311
4.
Lactoferrin-Bearing Gold Nanocages for Gene Delivery in Prostate Cancer Cells in vitro.
Int J Nanomedicine
; 16: 4391-4407, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34234433
5.
Octadecyl chain-bearing PEGylated poly(propyleneimine)-based dendrimersomes: physicochemical studies, redox-responsiveness, DNA condensation, cytotoxicity and gene delivery to cancer cells.
Biomater Sci
; 9(4): 1431-1448, 2021 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33404026
6.
PEGylation of polypropylenimine dendrimers: effects on cytotoxicity, DNA condensation, gene delivery and expression in cancer cells.
Sci Rep
; 8(1): 9410, 2018 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29925967
7.
Redox-sensitive, cholesterol-bearing PEGylated poly(propylene imine)-based dendrimersomes for drug and gene delivery to cancer cells.
Nanoscale
; 10(48): 22830-22847, 2018 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30488937
8.
Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12.
Drug Deliv
; 25(1): 679-689, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29493296
9.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
Cancer Res
; 65(18): 8079-84, 2005 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16166279
10.
Preferential liver gene expression with polypropylenimine dendrimers.
J Control Release
; 101(1-3): 247-58, 2005 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-15588909
11.
Enhanced gene expression in the brain following intravenous administration of lactoferrin-bearing polypropylenimine dendriplex.
J Control Release
; 217: 235-42, 2015 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26362697
12.
Therapeutic efficacy of intravenously administered transferrin-conjugated dendriplexes on prostate carcinomas.
Nanomedicine (Lond)
; 9(4): 421-34, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24910874
13.
Transferrin-bearing polypropylenimine dendrimer for targeted gene delivery to the brain.
J Control Release
; 188: 78-86, 2014 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24933602
14.
Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polypropylenimine polyplex.
Biomaterials
; 32(25): 5889-99, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21596431
15.
Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA.
J Control Release
; 143(2): 215-21, 2010 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-19944722
16.
Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles.
Pharm Res
; 21(1): 101-7, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14984263